Fluarix Related Clinical Trials
School Influenza Vaccine vs Standard of Care With Nested Trial of 2 Parent Notification Intensities [Completed]
Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects [Completed]
Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM [Completed]
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation) [Completed]
Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation. [Completed]
Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults [Completed]
Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects [Completed]
Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 Years [Completed]
Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza [Completed]
A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 [Completed]
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine [Completed]
Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years [Completed]
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects [Completed]
Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine [Completed]
Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Study [Completed]
Study of Quadrivalent Influenza Vaccine Among Adults [Completed]
A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults [Completed]
2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women [Completed]
Study to Evaluate the Consistency of Three Consecutive Production Lots of Influenza Vaccine in Healthy Subjects 18 to 49 Years Old [Completed]
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults [Completed]
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine [Active, not recruiting]
A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of Age [Completed]
Trial to Collect Safety Data and Sera for Immunogenicity Testing [Completed]
Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021)- Year 1, 2011 [Active, not recruiting]
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children [Completed]
Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine With and Without Adjuvant System 03 (AS03) [Active, not recruiting]
Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults for the 2015-2016 Season [Recruiting]
Influenza Vaccine in Pregnant Women [Completed]
Direct and Indirect Benefits of Influenza Vaccination in Schools and Households [Completed]
Study of Quadrivalent Influenza Vaccine Among Children [Completed]
Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza [Completed]
Safety and Immunogenicity Testing of Influenza Vaccine in Healthy Children 2 Months and 6 Months of Age [Completed]
Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women [Completed]
Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age [Completed]
A Study to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine in Children [Completed]
Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children 6 to 35 Months of Age [Completed]
Safety, Tolerability, and Immunogenicity Study of a Cell-based Virosomal Influenza Vaccine in Healthy Adults [Completed]
Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting [Completed]
Safety Study of FluMist With and Without Ampligen [Recruiting]
The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis [Recruiting]
Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & Adolescents [Completed]
Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally [Completed]
Clinical Efficacy of Trivalent Live-Attenuated Influenza Vaccine (LAIV) Among Children in Senegal [Completed]
Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A [Completed]
Brief Influenza Vaccine Education to Pregnant Women [Active, not recruiting]
Maternal Flu Vaccine Trial in Bamako, Mali [Active, not recruiting]
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older [Completed]
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine, Fluarix®/Influsplit SSW® (2013/2014 Season), in Adults 18 Years of Age and Older [Completed]
Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older [Completed]
Study of Parenterally Administrated Adjuvanted Seasonal Influenza Vaccine in Healthy Elderly Volunteers [Active, not recruiting]
Feasibility of Cocooning Immunization Strategy With Influenza Vaccine [Completed]
Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults [Completed]
Study of Seasonal Influenza Vaccine Against H5N1 Avian Influenza Virus [Completed]
Revaccination With Influenza Vaccine GSK1247446A [Completed]
A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older [Completed]
Two-site Intradermal Influenza Vaccination in Elderly [Recruiting]
A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months [Completed]
High Dose Influenza Vaccine in Nursing Home [Active, not recruiting]
Safety Trial of Live Attenuated Influenza (H7N3) Vaccine [Completed]
T-cell And General Immune Response to Seasonal Influenza Vaccine(SLVP018) [Active, not recruiting]
Immune Responses to the Flu Shot During Pregnancy [Recruiting]
Seasonal Influenza Vaccine Effectiveness Study in Kenya [Recruiting]
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV [Completed]
Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children [Completed]
Field Trial of Maternal Influenza Immunization in Asia [Recruiting]
Impact of Influenza Vaccination in Pregnancy Video Education [Completed]
Influenza Vaccine in HIV Infected Children [Completed]
Influenza Immunization of Children in India [Active, not recruiting]
A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly [Completed]
|